Objective: To investigate the clinical effect of the oral montelukast in early stage of bronchiolitis .

目的： 探讨早期口服孟鲁司特钠治疗毛细支气管炎的疗效。

The boy was empirically treated with 4 mg daily of Montelukast and all his symptoms resolved within 4 weeks.

男孩经验性地给予每日4毫克的孟鲁司特治疗，4个星期内所有症状皆消失。

Montelukast, a Selective Cysteinyl Leukotriene Receptor 1 Antagonist, Reduces Cerulein-Induced Pancreatic Injury in Rats.

孟鲁司特，选择性白三烯受体1拮抗物，能减少雨蛙肽诱导的胰腺损害。

Conclusion the clinical efficacy of Montelukast Sodium in the treatment of chronic obstructive pulmonary disease is obvious.

结论孟鲁司特钠在慢性阻塞性肺病治疗中临床疗效显著。